PLSM
Pulsenmore Ltd.
Price Chart
Latest Quote
$3.51
+0.06 (+1.74%)
Current Price
| Previous Close | $3.45 |
| Open | $3.51 |
| Day High | $3.51 |
| Day Low | $3.51 |
| Volume | 696 |
Stock Information
Note: Financial values converted from ILS to USD
| Shares Outstanding | 6.50M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $22.82M |
| EPS (TTM) | $-0.84 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Employees | 71 |
Financial Ratios
| Quick Ratio | 7.17 |
| Current Ratio | 7.88 |
| Debt/Eq | 1.88 |
Returns & Margins
| ROA | -6.24% |
| ROE | -17.62% |
| Gross Margin | 84.16% |
| Profit Margin | -39.61% |
Ownership
| Insider Ownership | 43.40% |
| Institutional Ownership | 5.21% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $4.21 |
| SMA50 | $3.94 |
| RSI | 12.71 |
| ATR | 0.2421 |
| Shares Float | 1.54M |
| Short Float | 0.07% |
| Short Ratio | 0.07 |
| Volatility | 0.42 |
| Rel Volume | 0.09 |
Performance History
| Week | -12.80% |
| Month | -12.25% |
| Quarter | -16.43% |
| YTD | -52.31% |
| 10 Years | -52.31% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $3.51 | 696 |
| 2026-06-18 | $3.45 | 10,600 |
| 2026-06-17 | $3.65 | 2,500 |
| 2026-06-16 | $3.85 | 6,600 |
| 2026-06-15 | $3.85 | 3,300 |
| 2026-06-12 | $4.03 | 8,200 |
| 2026-06-11 | $4.05 | 11,700 |
| 2026-06-10 | $4.07 | 7,300 |
| 2026-06-09 | $3.98 | 5,400 |
| 2026-06-08 | $4.23 | 9,400 |
| 2026-06-05 | $4.15 | 5,200 |
| 2026-06-04 | $4.36 | 11,400 |
| 2026-06-03 | $4.39 | 7,900 |
| 2026-06-02 | $4.68 | 17,100 |
| 2026-06-01 | $4.83 | 4,100 |
| 2026-05-29 | $4.65 | 8,300 |
| 2026-05-28 | $4.73 | 6,800 |
| 2026-05-27 | $4.70 | 8,500 |
| 2026-05-26 | $4.53 | 9,200 |
| 2026-05-22 | $4.49 | 10,100 |
About Pulsenmore Ltd.
Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products. The company was incorporated in 2014 and is based in Omer, Israel.
đ° Latest News
Pulsenmore to commence trading on Nasdaq
TipRanks âĸ 2026-01-23T15:06:41Z
Wall Street Set to Open Higher Thursday as Investors Parse GDP, Unemployment Data, Look Ahead to Inflation Report
MT Newswires âĸ 2026-01-22T14:25:55ZInvestors Await Raft of Key Economic Data as US Futures Rise Thursday Pre-Bell
MT Newswires âĸ 2026-01-22T13:13:26Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,653,147 | $1,561,887 | $902,454 | $1,626,107 |
| Cost Of Revenue | $2,143,581 | $2,056,378 | $1,347,597 | $1,923,207 |
| Total Revenue | $13,528,020 | $3,265,396 | $2,091,530 | $3,655,107 |
| Operating Revenue | $13,528,020 | $3,265,396 | $2,091,530 | $3,655,107 |
| Expenses | ||||
| Interest Expense | $106,469 | $169,675 | $198,067 | $109,173 |
| Total Expenses | $17,639,424 | $17,533,969 | $20,879,470 | $19,271,277 |
| Rent Expense Supplemental | $301,494 | $379,233 | $657,406 | $358,954 |
| Other Income Expense | $-1,879,943 | $186,575 | $-3,099,439 | $7,145,947 |
| Net Non Operating Interest Income Expense | $633,408 | $1,646,387 | $2,134,793 | $994,051 |
| Total Other Finance Cost | $455,621 | $-17,576 | $-16,562 | $-58,812 |
| Interest Expense Non Operating | $106,469 | $169,675 | $198,067 | $109,173 |
| Operating Expense | $15,495,843 | $15,477,591 | $19,531,873 | $17,348,070 |
| Selling And Marketing Expense | $1,722,436 | $1,563,915 | $1,277,293 | $1,231,326 |
| General And Administrative Expense | $7,451,835 | $6,640,303 | $7,274,724 | $5,963,293 |
| Other Operating Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-5,358,278 | $-12,416,684 | $-19,795,511 | $-7,476,171 |
| Net Interest Income | $633,408 | $1,646,387 | $2,134,793 | $994,051 |
| Interest Income | $1,195,498 | $1,798,486 | $2,316,298 | $1,044,413 |
| Normalized Income | $-3,910,721 | $-12,602,974 | $-17,408,943 | $-14,622,118 |
| Net Income From Continuing And Discontinued Operation | $-5,358,278 | $-12,416,684 | $-19,795,511 | $-7,476,171 |
| Total Operating Income As Reported | $-4,111,404 | $-14,268,573 | $-18,787,940 | $-15,616,170 |
| Net Income Common Stockholders | $-5,358,278 | $-12,416,684 | $-19,795,511 | $-7,476,171 |
| Net Income | $-5,358,278 | $-12,416,684 | $-19,795,511 | $-7,476,171 |
| Net Income Including Noncontrolling Interests | $-5,358,278 | $-12,416,684 | $-19,795,511 | $-7,476,171 |
| Net Income Continuous Operations | $-5,358,278 | $-12,416,684 | $-19,795,511 | $-7,476,171 |
| Pretax Income | $-5,357,940 | $-12,435,611 | $-19,752,586 | $-7,476,171 |
| Interest Income Non Operating | $1,195,498 | $1,798,486 | $2,316,298 | $1,044,413 |
| Operating Income | $-4,111,404 | $-14,268,573 | $-18,787,940 | $-15,616,170 |
| Depreciation Amortization Depletion Income Statement | $457,311 | $469,479 | $367,066 | $140,945 |
| Depreciation And Amortization In Income Statement | $457,311 | $469,479 | $367,066 | $140,945 |
| Depreciation Income Statement | $457,311 | $469,479 | $367,066 | $140,945 |
| Gross Profit | $11,384,439 | $1,209,018 | $743,933 | $1,731,900 |
| Per Share | ||||
| Diluted EPS | $-0.83 | $-1.95 | $-3.08 | $-1.24 |
| Basic EPS | $-0.83 | $-1.95 | $-3.08 | $-1.24 |
| Other | ||||
| Tax Effect Of Unusual Items | $-432,387 | $284 | $-712,871 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,423,782 | $-11,488,542 | $-15,642,872 | $-14,074,900 |
| Total Unusual Items | $-1,879,943 | $186,575 | $-3,099,439 | $7,145,947 |
| Total Unusual Items Excluding Goodwill | $-1,879,943 | $186,575 | $-3,099,439 | $7,145,947 |
| Reconciled Depreciation | $947,746 | $963,969 | $812,208 | $438,045 |
| EBITDA (Bullshit earnings) | $-4,303,725 | $-11,301,967 | $-18,742,310 | $-6,928,953 |
| EBIT | $-5,251,470 | $-12,265,937 | $-19,554,519 | $-7,366,998 |
| Diluted Average Shares | $2,177,653 | $2,164,780 | $2,164,236 | $2,039,146 |
| Basic Average Shares | $2,177,653 | $2,164,780 | $2,164,236 | $2,039,146 |
| Diluted NI Availto Com Stockholders | $-5,358,278 | $-12,416,684 | $-19,795,511 | $-7,476,171 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Tax Provision | $338 | $-18,928 | $42,926 | $0 |
| Gain On Sale Of Security | $-1,879,943 | $186,575 | $-3,099,439 | $7,145,947 |
| Research And Development | $5,864,260 | $6,803,894 | $10,612,790 | $10,012,506 |
| Selling General And Administration | $9,174,272 | $8,204,218 | $8,552,018 | $7,194,619 |
| Other Gand A | $1,766,038 | $1,478,740 | $1,717,366 | $1,475,360 |
| Insurance And Claims | $99,033 | $117,961 | $67,262 | $168,661 |
| Rent And Landing Fees | $301,494 | $379,233 | $657,406 | $358,954 |
| Salaries And Wages | $5,285,270 | $4,664,368 | $4,832,691 | $3,960,319 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $28,084,229 | $32,747,583 | $44,694,112 | $63,380,653 |
| Total Assets | $34,424,052 | $47,936,862 | $60,808,490 | $79,870,209 |
| Total Non Current Assets | $6,910,025 | $3,185,628 | $4,063,746 | $8,351,923 |
| Other Non Current Assets | $4,507,875 | - | - | - |
| Current Assets | $27,514,027 | $44,751,233 | $56,744,744 | $71,518,285 |
| Restricted Cash | $47,320 | $47,320 | $47,320 | $47,320 |
| Prepaid Assets | $219,023 | $197,729 | $149,395 | $899,074 |
| Inventory | $2,228,419 | $7,805,043 | $8,007,166 | $4,816,129 |
| Receivables | $1,651,795 | $1,541,608 | $639,492 | $3,842,358 |
| Other Receivables | $251,132 | $220,375 | $314,338 | $487,055 |
| Accounts Receivable | $1,400,662 | $1,321,233 | $325,154 | $3,355,303 |
| Cash Cash Equivalents And Short Term Investments | $23,367,471 | $35,159,535 | $47,901,372 | $61,913,405 |
| Cash And Cash Equivalents | $7,302,102 | $13,915,365 | $8,067,667 | $5,194,349 |
| Cash Financial | $7,302,102 | $13,915,365 | $8,067,667 | $5,194,349 |
| Financial Assets | - | - | $0 | $5,271,074 |
| Debt | ||||
| Total Debt | $528,966 | $716,217 | $1,125,532 | $1,340,499 |
| Long Term Debt And Capital Lease Obligation | $183,195 | $378,557 | $813,560 | $1,048,807 |
| Current Debt And Capital Lease Obligation | $345,772 | $337,660 | $311,972 | $291,692 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $6,339,823 | $15,189,279 | $16,114,378 | $16,489,556 |
| Total Non Current Liabilities Net Minority Interest | $2,848,645 | $10,369,093 | $10,870,006 | $11,234,368 |
| Other Non Current Liabilities | $2,665,450 | $2,195,971 | $2,181,437 | $2,076,658 |
| Non Current Deferred Liabilities | $0 | $7,739,133 | $7,739,133 | $7,683,364 |
| Current Liabilities | $3,491,178 | $4,820,185 | $5,244,372 | $5,255,188 |
| Other Current Liabilities | $576,286 | $179,815 | $261,272 | $325,154 |
| Current Deferred Liabilities | $317,042 | $1,734,942 | $1,734,942 | $1,737,646 |
| Payables And Accrued Expenses | $1,240,452 | $1,388,495 | $2,295,004 | $2,559,319 |
| Payables | $1,238,086 | $1,387,143 | $2,268,303 | $2,553,235 |
| Other Payable | $568,850 | $589,806 | $604,002 | $572,568 |
| Accounts Payable | $669,235 | $797,337 | $1,664,301 | $1,980,667 |
| Tradeand Other Payables Non Current | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $28,084,229 | $32,747,583 | $44,694,112 | $63,380,653 |
| Total Equity Gross Minority Interest | $28,084,229 | $32,747,583 | $44,694,112 | $63,380,653 |
| Stockholders Equity | $28,084,229 | $32,747,583 | $44,694,112 | $63,380,653 |
| Other Equity Interest | $3,411,073 | $3,707,159 | $3,484,418 | $2,441,695 |
| Gains Losses Not Affecting Retained Earnings | $3,411,073 | $3,707,159 | - | - |
| Other Equity Adjustments | $3,411,073 | $3,707,159 | - | - |
| Retained Earnings | $-61,901,237 | $-56,542,959 | $-44,126,276 | $-24,330,764 |
| Other | ||||
| Ordinary Shares Number | $2,197,946 | $2,119,795 | $2,113,035 | $2,109,008 |
| Share Issued | $2,197,946 | $2,119,795 | $2,113,035 | $2,109,008 |
| Tangible Book Value | $28,084,229 | $32,747,583 | $44,694,112 | $63,380,653 |
| Invested Capital | $28,084,229 | $32,747,583 | $44,694,112 | $63,380,653 |
| Working Capital | $24,022,849 | $39,931,048 | $51,500,372 | $66,263,097 |
| Capital Lease Obligations | $528,966 | $716,217 | $1,125,532 | $1,340,499 |
| Total Capitalization | $28,084,229 | $32,747,583 | $44,694,112 | $63,380,653 |
| Additional Paid In Capital | $86,573,717 | $85,582,708 | $85,335,293 | $85,269,046 |
| Capital Stock | $676 | $676 | $676 | $676 |
| Common Stock | $676 | $676 | $676 | $676 |
| Employee Benefits | $0 | $55,432 | $135,875 | $425,539 |
| Non Current Pension And Other Postretirement Benefit Plans | $0 | $55,432 | $135,875 | $425,539 |
| Non Current Deferred Revenue | $0 | $7,739,133 | $7,739,133 | $7,683,364 |
| Long Term Capital Lease Obligation | $183,195 | $378,557 | $813,560 | $1,048,807 |
| Current Deferred Revenue | $317,042 | $1,734,942 | $1,734,942 | $1,737,646 |
| Current Capital Lease Obligation | $345,772 | $337,660 | $311,972 | $291,692 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,011,627 | $1,179,274 | $641,182 | $341,378 |
| Current Accrued Expenses | $2,366 | $1,352 | $26,702 | $6,084 |
| Net PPE | $2,402,150 | $3,185,628 | $4,063,746 | $3,080,849 |
| Accumulated Depreciation | $-3,464,814 | $-2,475,833 | $-1,511,864 | $-699,655 |
| Gross PPE | $5,866,964 | $5,661,461 | $5,575,610 | $3,780,504 |
| Leases | $1,657,541 | $1,497,668 | - | - |
| Machinery Furniture Equipment | $4,209,423 | $4,163,794 | $3,955,925 | $2,171,635 |
| Buildings And Improvements | $1,657,541 | $1,497,668 | $1,619,685 | $1,608,869 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $719,597 | $1,687,285 | $1,984,046 | $25,012 |
| Work In Process | $112,891 | $40,560 | $237,274 | $33,462 |
| Raw Materials | $1,395,931 | $6,077,199 | $5,785,845 | $4,757,656 |
| Other Short Term Investments | $16,065,369 | $21,244,169 | $39,833,705 | $56,719,056 |
| Other Properties | - | $5,661,461 | $5,575,610 | $3,780,504 |
| Other Inventories | - | $1,727,844 | $2,221,321 | $58,474 |
| Preferred Stock | - | - | - | - |
| Dueto Related Parties Non Current | - | - | - | - |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-11,157,642 | $-14,185,763 | $-18,113,297 | $-10,825,728 |
| Operating Activities | ||||
| Operating Cash Flow | $-11,112,012 | $-14,013,723 | $-16,786,318 | $-9,302,711 |
| Cash Flow From Continuing Operating Activities | $-11,112,012 | $-14,013,723 | $-16,786,318 | $-9,302,711 |
| Operating Gains Losses | $1,696,748 | $-186,575 | $-2,171,635 | $-3,684,513 |
| Investing Activities | ||||
| Capital Expenditure | $-45,630 | $-172,041 | $-1,326,979 | $-1,523,018 |
| Investing Cash Flow | $4,680,592 | $19,800,243 | $19,166,836 | $-42,098,966 |
| Cash Flow From Continuing Investing Activities | $4,680,592 | $19,800,243 | $19,166,836 | $-42,098,966 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $8,450 | $1,014 | $0 | $17,295,680 |
| Financing Cash Flow | $1,352 | $-528,628 | $-386,669 | $17,226,729 |
| Cash Flow From Continuing Financing Activities | $1,352 | $-528,628 | $-386,669 | $17,226,729 |
| Net Other Financing Charges | $446,495 | $-36,504 | $65,910 | $365,038 |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Net Common Stock Issuance | $8,450 | $1,014 | $0 | $17,295,680 |
| Common Stock Issuance | $8,450 | $1,014 | $0 | $17,295,680 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-397,823 | $-394,443 | $-335,970 | $-63,544 |
| End Cash Position | $7,302,102 | $13,915,365 | $8,067,667 | $5,194,349 |
| Beginning Cash Position | $13,915,365 | $8,067,667 | $5,194,349 | $38,147,096 |
| Effect Of Exchange Rate Changes | $-183,195 | $589,806 | $879,470 | $1,222,200 |
| Changes In Cash | $-6,430,068 | $5,257,892 | $1,993,848 | $-34,174,947 |
| Interest Paid Cff | $-55,770 | $-98,695 | $-117,285 | $-370,783 |
| Proceeds From Stock Option Exercised | $8,450 | $1,014 | $676 | $338 |
| Net Issuance Payments Of Debt | $-397,823 | $-394,443 | $-335,970 | $-63,544 |
| Net Long Term Debt Issuance | $-397,823 | $-394,443 | $-335,970 | $-63,544 |
| Long Term Debt Payments | $-397,823 | $-394,443 | $-335,970 | $-63,544 |
| Interest Received Cfi | $1,137,700 | $2,592,780 | $2,316,298 | $846,008 |
| Net Investment Purchase And Sale | $3,588,522 | $17,379,504 | $18,177,516 | $-41,421,956 |
| Sale Of Investment | $3,588,522 | $17,379,504 | $18,177,516 | $59,784,019 |
| Net PPE Purchase And Sale | $-45,630 | $-172,041 | $-1,326,979 | $-1,523,018 |
| Purchase Of PPE | $-45,630 | $-172,041 | $-1,326,979 | $-1,523,018 |
| Change In Working Capital | $-8,129,859 | $-1,197,188 | $132,495 | $3,420,199 |
| Change In Other Working Capital | $-9,157,034 | - | $53,066 | $6,933,347 |
| Change In Other Current Liabilities | $6,084 | $39,546 | $83,147 | $147,029 |
| Change In Other Current Assets | $-9,157,034 | $0 | $53,066 | $6,933,347 |
| Change In Payables And Accrued Expense | $83,823 | $-488,407 | $-337,322 | $1,882,309 |
| Change In Payable | $83,823 | $-488,407 | $-337,322 | $1,882,309 |
| Change In Account Payable | $-128,101 | $-866,964 | $-316,366 | $1,700,128 |
| Change In Inventory | $1,068,749 | $202,123 | $-3,191,036 | $-3,301,224 |
| Change In Receivables | $-131,481 | $-950,450 | $3,524,640 | $-2,241,263 |
| Changes In Account Receivables | $-131,481 | $-950,450 | $3,524,640 | $-2,241,263 |
| Other Non Cash Items | $-493,815 | $-1,646,387 | $3,127,831 | $-3,599,338 |
| Stock Based Compensation | $225,444 | $469,141 | $1,108,294 | $1,599,067 |
| Depreciation Amortization Depletion | $947,746 | $963,969 | $812,208 | $438,045 |
| Depreciation And Amortization | $947,746 | $963,969 | $812,208 | $438,045 |
| Depreciation | $947,746 | $963,969 | $812,208 | $438,045 |
| Net Foreign Currency Exchange Gain Loss | $1,696,748 | $-186,575 | $-2,171,635 | $-3,684,513 |
| Net Income From Continuing Operations | $-5,358,278 | $-12,416,684 | $-19,795,511 | $-7,476,171 |
| Purchase Of Investment | - | - | - | $-101,205,975 |
| Unrealized Gain Loss On Investment Securities | - | - | - | $0 |
| Gain Loss On Sale Of PPE | - | - | - | $0 |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-06-20